Log in

Fendiline-β-Cyclodextrin inclusion complex

  • Published:
Journal of inclusion phenomena Aims and scope Submit manuscript

Abstract

Fendiline (N-[1-phenylethyl]-3,3-diphenylpropylamine hydrochloride, trade name: Sensit) is a β-receptor blocker and a Ca antagonist. It is a viscous oil and even its crystalline hydrochloride is a very hydrophobic and sparingly soluble compound in water.β-Cyclodextrin complexes fendiline base in a molar ratio of 2∶1. In aqueousβ-cyclodextrin solution, the significantly increased solubility and the intensive induced circular dichroism prove the formation of true inclusion complexes with both the base and the hydrochloride. In artificial gastric juice, the solubility of the complexed forms of the fendiline base and its hydrochloride is 40 and 22 times higher, respectively, than that of free drugs. The complexation withβCD resulted in a two-threefold increase in the rate constants of diffusion and absorption determined in a Sartorius apparatus.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Hungarian Patent 150534 (1961).

  2. J. Szejtli:Die Stärke 33, 387 (1981).

    Google Scholar 

  3. J. Szejtli and L. Szente:Die Pharmazie 36, 694 (1981).

    Google Scholar 

  4. J. Szejtli, A. Gerlóczy, and A. Fónagy:Die Pharmazie 38, 100 (1983).

    Google Scholar 

  5. J. Pitha, L. Szente, and J. Szejtli: inControlled Drug Delivery Vol.1 (ed.: S. D. Bruck); p. 124, CRC Press, Boca Raton, Florida, (1983).

    Google Scholar 

  6. K. Koizumi and Y. Kidera:Yakugaku Zasshi 97, 705 (1977).

    Google Scholar 

  7. K. Uekama, N. Matsuo, F. Hirayama, T. Yamaguchi, Y. Imamura, and H. Ichibagase,:Chem. Pharm. Bull. 27, 398 (1979).

    Google Scholar 

  8. Hungarian patent 178755 (1979).

  9. J. Szejtli:Cyclodextrins and their Inclusion Complexes, Akadémiai Kiadó, Budapest (1982).

    Google Scholar 

  10. M. Kajtár, Cs. Horváth Toró, É. Kuthi, and J. Szejtli:Acta Chim. Hung. 110, 327 (1982).

    Google Scholar 

  11. H. A. Benesi and J. H. Hildebrand:J. Am. Chem. Soc. 71, 2703 (1949).

    Google Scholar 

  12. H. Stricker:Pharm. Ind. 33, 157 (1971).

    Google Scholar 

  13. H. Stricker:Drugs in Germany 14, 93 (1971).

    Google Scholar 

  14. M. Kurcz, V. Pálosi-Szánthó, K. Urbán Szabó, K. Lánczi-Ács, and M. Kucsera:Symposium of the Hungarian and Polish Pharmacol. Soc. on Pharmakokinetic Aspects of Drug Research, Visegrád, 15–18 May 1983 (Hungary).

  15. M. Kurcz, K. Tòth, and U. Pálosi-Szánthó: inNew Approaches in Liquid Chromatography (Ed.: H. Kalász), Akadémiai Kiadó, Budapest (in press).

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stadler-Szöke, Á., Vikmon, M., Szejtli, J. et al. Fendiline-β-Cyclodextrin inclusion complex. Journal of Inclusion Phenomena 3, 71–84 (1985). https://doi.org/10.1007/BF00658864

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00658864

Key words

Navigation